100% Quality Guarantee
PhD-Level Technical Support
Anti-CS1 elotuzumab biosimilar mAb HDBS0002
Key Features

Elotuzumab Biosimilar (CS1) Antibody (HDBS0002)

SKU HDBS0002
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein CS1
Reactivity Human
Host Species Humanized
Isotype IgG1
$569

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Elotuzumab Biosimilar (CS1) Antibody (HDBS0002)

The CS1 Elotuzumab Biosimilar (MAB-HDBS0002) is a monoclonal antibody designed for research involving CS1, a cell surface glycoprotein commonly found on multiple myeloma cells. This biosimilar antibody, similar to Elotuzumab, is highly specific and binds to CS1 with high affinity, allowing for the detection and analysis of CS1-expressing cells.CS1, also known as SLAMF7, plays a crucial role in multiple myeloma cell survival and proliferation, making it a promising target for immunotherapy. The CS1 Elotuzumab Biosimilar offers researchers a valuable tool for studying the mechanisms of action of CS1 and exploring its potential as a therapeutic target in the treatment of multiple myeloma.

With its high specificity and affinity for CS1, this biosimilar antibody is suitable for various research applications, including flow cytometry, immunohistochemistry, and functional assays. Its reliable performance and consistent results make it an essential tool for advancing our understanding of CS1 biology and developing novel treatment strategies for multiple myeloma.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose